nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Rifampicin—leprosy	0.183	0.548	CbGbCtD
Tadalafil—CYP3A4—Dapsone—leprosy	0.151	0.452	CbGbCtD
Tadalafil—Sinus bradycardia—Thalidomide—leprosy	0.0215	0.0335	CcSEcCtD
Tadalafil—Transient ischaemic attack—Thalidomide—leprosy	0.0209	0.0326	CcSEcCtD
Tadalafil—Metrorrhagia—Thalidomide—leprosy	0.0148	0.023	CcSEcCtD
Tadalafil—Nasopharyngitis—Dapsone—leprosy	0.0134	0.0209	CcSEcCtD
Tadalafil—Influenza—Dapsone—leprosy	0.0129	0.0202	CcSEcCtD
Tadalafil—Musculoskeletal stiffness—Thalidomide—leprosy	0.0118	0.0183	CcSEcCtD
Tadalafil—Bone disorder—Thalidomide—leprosy	0.0117	0.0182	CcSEcCtD
Tadalafil—Hearing impaired—Thalidomide—leprosy	0.0111	0.0173	CcSEcCtD
Tadalafil—Neck pain—Thalidomide—leprosy	0.0107	0.0167	CcSEcCtD
Tadalafil—Pharyngitis—Dapsone—leprosy	0.0103	0.016	CcSEcCtD
Tadalafil—Tinnitus—Dapsone—leprosy	0.00966	0.015	CcSEcCtD
Tadalafil—Oesophagitis—Thalidomide—leprosy	0.00965	0.015	CcSEcCtD
Tadalafil—Gastroenteritis—Thalidomide—leprosy	0.00865	0.0135	CcSEcCtD
Tadalafil—Deafness—Thalidomide—leprosy	0.00857	0.0133	CcSEcCtD
Tadalafil—Vision blurred—Dapsone—leprosy	0.0085	0.0132	CcSEcCtD
Tadalafil—Eye pain—Thalidomide—leprosy	0.0085	0.0132	CcSEcCtD
Tadalafil—Amnesia—Thalidomide—leprosy	0.00816	0.0127	CcSEcCtD
Tadalafil—Dermatitis exfoliative—Thalidomide—leprosy	0.00813	0.0127	CcSEcCtD
Tadalafil—Vertigo—Dapsone—leprosy	0.00811	0.0126	CcSEcCtD
Tadalafil—Cough—Dapsone—leprosy	0.00787	0.0123	CcSEcCtD
Tadalafil—Cerebrovascular accident—Thalidomide—leprosy	0.00783	0.0122	CcSEcCtD
Tadalafil—Pain in extremity—Thalidomide—leprosy	0.00767	0.0119	CcSEcCtD
Tadalafil—Migraine—Thalidomide—leprosy	0.00755	0.0118	CcSEcCtD
Tadalafil—Face oedema—Thalidomide—leprosy	0.0074	0.0115	CcSEcCtD
Tadalafil—Tachycardia—Dapsone—leprosy	0.00719	0.0112	CcSEcCtD
Tadalafil—Liver function test abnormal—Thalidomide—leprosy	0.00708	0.011	CcSEcCtD
Tadalafil—Orthostatic hypotension—Thalidomide—leprosy	0.007	0.0109	CcSEcCtD
Tadalafil—Breast disorder—Thalidomide—leprosy	0.00693	0.0108	CcSEcCtD
Tadalafil—Insomnia—Dapsone—leprosy	0.00666	0.0104	CcSEcCtD
Tadalafil—Influenza—Thalidomide—leprosy	0.00663	0.0103	CcSEcCtD
Tadalafil—Dysphagia—Thalidomide—leprosy	0.00663	0.0103	CcSEcCtD
Tadalafil—Angina pectoris—Thalidomide—leprosy	0.00646	0.0101	CcSEcCtD
Tadalafil—Bronchitis—Thalidomide—leprosy	0.00638	0.00993	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Thalidomide—leprosy	0.00616	0.00959	CcSEcCtD
Tadalafil—Gastrointestinal pain—Dapsone—leprosy	0.00602	0.00938	CcSEcCtD
Tadalafil—Infestation NOS—Thalidomide—leprosy	0.00591	0.0092	CcSEcCtD
Tadalafil—Infestation—Thalidomide—leprosy	0.00591	0.0092	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00586	0.00912	CcSEcCtD
Tadalafil—Acute coronary syndrome—Thalidomide—leprosy	0.00583	0.00907	CcSEcCtD
Tadalafil—Abdominal pain—Dapsone—leprosy	0.00582	0.00906	CcSEcCtD
Tadalafil—Renal failure—Thalidomide—leprosy	0.00581	0.00905	CcSEcCtD
Tadalafil—Myocardial infarction—Thalidomide—leprosy	0.00579	0.00902	CcSEcCtD
Tadalafil—Conjunctivitis—Thalidomide—leprosy	0.00575	0.00894	CcSEcCtD
Tadalafil—PDE5A—blood vessel—leprosy	0.00573	0.236	CbGeAlD
Tadalafil—Sweating—Thalidomide—leprosy	0.00567	0.00882	CcSEcCtD
Tadalafil—Haematuria—Thalidomide—leprosy	0.00564	0.00877	CcSEcCtD
Tadalafil—Epistaxis—Thalidomide—leprosy	0.00557	0.00868	CcSEcCtD
Tadalafil—Rhinitis—Thalidomide—leprosy	0.00532	0.00828	CcSEcCtD
Tadalafil—PDE11A—tendon—leprosy	0.00531	0.218	CbGeAlD
Tadalafil—Hypoaesthesia—Thalidomide—leprosy	0.00528	0.00822	CcSEcCtD
Tadalafil—Pharyngitis—Thalidomide—leprosy	0.00527	0.0082	CcSEcCtD
Tadalafil—Urinary tract disorder—Thalidomide—leprosy	0.00524	0.00816	CcSEcCtD
Tadalafil—Oedema peripheral—Thalidomide—leprosy	0.00523	0.00814	CcSEcCtD
Tadalafil—Urethral disorder—Thalidomide—leprosy	0.0052	0.0081	CcSEcCtD
Tadalafil—Erythema multiforme—Thalidomide—leprosy	0.00502	0.00781	CcSEcCtD
Tadalafil—Eye disorder—Thalidomide—leprosy	0.00496	0.00772	CcSEcCtD
Tadalafil—Tinnitus—Thalidomide—leprosy	0.00495	0.0077	CcSEcCtD
Tadalafil—Cardiac disorder—Thalidomide—leprosy	0.00492	0.00767	CcSEcCtD
Tadalafil—Angiopathy—Thalidomide—leprosy	0.00481	0.0075	CcSEcCtD
Tadalafil—Immune system disorder—Thalidomide—leprosy	0.00479	0.00746	CcSEcCtD
Tadalafil—Mediastinal disorder—Thalidomide—leprosy	0.00478	0.00745	CcSEcCtD
Tadalafil—Vomiting—Dapsone—leprosy	0.00468	0.00729	CcSEcCtD
Tadalafil—Mental disorder—Thalidomide—leprosy	0.00465	0.00724	CcSEcCtD
Tadalafil—Headache—Dapsone—leprosy	0.00461	0.00718	CcSEcCtD
Tadalafil—Back pain—Thalidomide—leprosy	0.00447	0.00696	CcSEcCtD
Tadalafil—Muscle spasms—Thalidomide—leprosy	0.00444	0.00691	CcSEcCtD
Tadalafil—PDE11A—testis—leprosy	0.0044	0.181	CbGeAlD
Tadalafil—Nausea—Dapsone—leprosy	0.00437	0.00681	CcSEcCtD
Tadalafil—Vision blurred—Thalidomide—leprosy	0.00435	0.00678	CcSEcCtD
Tadalafil—Angioedema—Thalidomide—leprosy	0.00422	0.00657	CcSEcCtD
Tadalafil—Vertigo—Thalidomide—leprosy	0.00415	0.00646	CcSEcCtD
Tadalafil—Syncope—Thalidomide—leprosy	0.00414	0.00645	CcSEcCtD
Tadalafil—Palpitations—Thalidomide—leprosy	0.00408	0.00636	CcSEcCtD
Tadalafil—Loss of consciousness—Thalidomide—leprosy	0.00406	0.00632	CcSEcCtD
Tadalafil—Cough—Thalidomide—leprosy	0.00403	0.00628	CcSEcCtD
Tadalafil—Convulsion—Thalidomide—leprosy	0.004	0.00623	CcSEcCtD
Tadalafil—Hypertension—Thalidomide—leprosy	0.00399	0.00621	CcSEcCtD
Tadalafil—Myalgia—Thalidomide—leprosy	0.00393	0.00612	CcSEcCtD
Tadalafil—Arthralgia—Thalidomide—leprosy	0.00393	0.00612	CcSEcCtD
Tadalafil—Chest pain—Thalidomide—leprosy	0.00393	0.00612	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00391	0.00608	CcSEcCtD
Tadalafil—Discomfort—Thalidomide—leprosy	0.00389	0.00605	CcSEcCtD
Tadalafil—Dry mouth—Thalidomide—leprosy	0.00385	0.00599	CcSEcCtD
Tadalafil—Oedema—Thalidomide—leprosy	0.00377	0.00587	CcSEcCtD
Tadalafil—Infection—Thalidomide—leprosy	0.00374	0.00583	CcSEcCtD
Tadalafil—Shock—Thalidomide—leprosy	0.00371	0.00577	CcSEcCtD
Tadalafil—Nervous system disorder—Thalidomide—leprosy	0.0037	0.00576	CcSEcCtD
Tadalafil—Tachycardia—Thalidomide—leprosy	0.00368	0.00573	CcSEcCtD
Tadalafil—Skin disorder—Thalidomide—leprosy	0.00366	0.0057	CcSEcCtD
Tadalafil—Hyperhidrosis—Thalidomide—leprosy	0.00364	0.00567	CcSEcCtD
Tadalafil—Hypotension—Thalidomide—leprosy	0.00352	0.00548	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Thalidomide—leprosy	0.00343	0.00535	CcSEcCtD
Tadalafil—Insomnia—Thalidomide—leprosy	0.00341	0.00531	CcSEcCtD
Tadalafil—Paraesthesia—Thalidomide—leprosy	0.00338	0.00527	CcSEcCtD
Tadalafil—Dyspnoea—Thalidomide—leprosy	0.00336	0.00523	CcSEcCtD
Tadalafil—Somnolence—Thalidomide—leprosy	0.00335	0.00522	CcSEcCtD
Tadalafil—Dyspepsia—Thalidomide—leprosy	0.00332	0.00517	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Thalidomide—leprosy	0.00325	0.00507	CcSEcCtD
Tadalafil—Fatigue—Thalidomide—leprosy	0.00325	0.00506	CcSEcCtD
Tadalafil—Pain—Thalidomide—leprosy	0.00322	0.00502	CcSEcCtD
Tadalafil—Constipation—Thalidomide—leprosy	0.00322	0.00502	CcSEcCtD
Tadalafil—Gastrointestinal pain—Thalidomide—leprosy	0.00308	0.0048	CcSEcCtD
Tadalafil—PDE5A—eye—leprosy	0.00305	0.125	CbGeAlD
Tadalafil—Urticaria—Thalidomide—leprosy	0.00299	0.00466	CcSEcCtD
Tadalafil—Abdominal pain—Thalidomide—leprosy	0.00298	0.00464	CcSEcCtD
Tadalafil—Hypersensitivity—Thalidomide—leprosy	0.00278	0.00432	CcSEcCtD
Tadalafil—Asthenia—Thalidomide—leprosy	0.0027	0.00421	CcSEcCtD
Tadalafil—Pruritus—Thalidomide—leprosy	0.00267	0.00415	CcSEcCtD
Tadalafil—Diarrhoea—Thalidomide—leprosy	0.00258	0.00402	CcSEcCtD
Tadalafil—Dizziness—Thalidomide—leprosy	0.00249	0.00388	CcSEcCtD
Tadalafil—Vomiting—Thalidomide—leprosy	0.0024	0.00373	CcSEcCtD
Tadalafil—Rash—Thalidomide—leprosy	0.00238	0.0037	CcSEcCtD
Tadalafil—Dermatitis—Thalidomide—leprosy	0.00237	0.0037	CcSEcCtD
Tadalafil—Headache—Thalidomide—leprosy	0.00236	0.00368	CcSEcCtD
Tadalafil—Nausea—Thalidomide—leprosy	0.00224	0.00349	CcSEcCtD
Tadalafil—PDE5A—tendon—leprosy	0.00202	0.083	CbGeAlD
Tadalafil—PDE5A—testis—leprosy	0.00167	0.0687	CbGeAlD
Tadalafil—PDE5A—nervous system—leprosy	0.00164	0.0675	CbGeAlD
Tadalafil—CYP3A4—nervous system—leprosy	0.000512	0.021	CbGeAlD
